Benlysta (belimumab) - GSK
Saphnelo (anifrolumab-fnia) - AstraZeneca
Incident Lupus Nephritis After Anifrolumab Versus Belimumab in Systemic Lupus Erythematosus: A Propensity-Matched Cohort Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #1226; Pres time: Nov 9, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3568342
 
Aseed Mestarihi, MD
 
Sep 8, 2026
 
Prev Next